RT Journal Article
SR Electronic
T1 Efficient Synthesis of 3D MR Images for Schizophrenia Diagnosis Classification with Generative Adversarial Networks
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.01.24308319
DO 10.1101/2024.06.01.24308319
A1 King, Sebastian
A1 Hollenbenders, Yasmin
A1 Reichenbach, Alexandra
YR 2024
UL http://medrxiv.org/content/early/2024/06/04/2024.06.01.24308319.abstract
AB Schizophrenia and other psychiatric disorders can greatly benefit from objective decision support in diagnosis and therapy. Machine learning approaches based on neuroimaging, e.g. magnetic resonance imaging (MRI), have the potential to serve this purpose. However, the medical data sets these algorithms can be trained on are often rather small, leading to overfit, and the resulting models can therewith not be transferred into a clinical setting. The generation of synthetic images from real data is a promising approach to overcome this shortcoming. Due to the small data set size and the size and complexity of medical images, i.e. their three-dimensional nature, those algorithms are challenged on several levels. We develop four generative adversarial network (GAN) architectures that tackle these challenges and evaluate them systematically with a data set of 193 MR images of schizophrenia patients and healthy controls. The best architecture, a GAN with spectral normalization regulation and an additional encoder (α-SN-GAN), is then extended with an auxiliary classifier into an ensemble of networks capable of generating distinct image sets for the two diagnostic categories. The synthetic images increase the accuracy of a diagnostic classifier from a baseline accuracy of around 61% to 79%. This novel end-to-end pipeline for schizophrenia diagnosis demonstrates a data and memory efficient approach to support clinical decision-making that can also be transferred to support other psychiatric disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGrant KK5207801BM0 from the Federal Ministry for Economic Affairs and Climate Action (BMWK) on the basis of a decision by the German Bundestag.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data set used in this study was obtained from the MCIC collection in July 2019: https://www.nitrc.org/projects/mcic/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData is available via the MCIC collection (https://www.nitrc.org/projects/mcic/). https://www.nitrc.org/projects/mcic/